The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Long-Acting Injectables-Global Market Insights and Sales Trends 2024
Synopsis
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
The global Long-Acting Injectables market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Long-Acting Injectables in various end use industries. The expanding demands from the Schizophrenia and Other Psychotic Disorders, are propelling Long-Acting Injectables market. Small and Middle Sized Molecule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Large Sized Molecule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Long-Acting Injectables market, driven by demand from China, the second largest economy with some signs of stabilising, the Long-Acting Injectables market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Long-Acting Injectables, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Long-Acting Injectables market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Long-Acting Injectables market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Long-Acting Injectables sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Long-Acting Injectables covered in this report include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, Lupin, Zogenix, DURECT and Medincel, etc.
The global Long-Acting Injectables market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Global Long-Acting Injectables market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Long-Acting Injectables market, Segment by Type:
Small and Middle Sized Molecule
Large Sized Molecule
Global Long-Acting Injectables market, by Application
Schizophrenia
Other Psychotic Disorders
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Long-Acting Injectables companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
The global Long-Acting Injectables market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Long-Acting Injectables in various end use industries. The expanding demands from the Schizophrenia and Other Psychotic Disorders, are propelling Long-Acting Injectables market. Small and Middle Sized Molecule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Large Sized Molecule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Long-Acting Injectables market, driven by demand from China, the second largest economy with some signs of stabilising, the Long-Acting Injectables market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Long-Acting Injectables, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Long-Acting Injectables market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Long-Acting Injectables market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Long-Acting Injectables sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Long-Acting Injectables covered in this report include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, Lupin, Zogenix, DURECT and Medincel, etc.
The global Long-Acting Injectables market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Global Long-Acting Injectables market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Long-Acting Injectables market, Segment by Type:
Small and Middle Sized Molecule
Large Sized Molecule
Global Long-Acting Injectables market, by Application
Schizophrenia
Other Psychotic Disorders
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Long-Acting Injectables companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Long-Acting Injectables
1.1 Long-Acting Injectables Market Overview
1.1.1 Long-Acting Injectables Product Scope
1.1.2 Long-Acting Injectables Market Status and Outlook
1.2 Global Long-Acting Injectables Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Long-Acting Injectables Market Size by Region (2018-2029)
1.4 Global Long-Acting Injectables Historic Market Size by Region (2018-2023)
1.5 Global Long-Acting Injectables Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Long-Acting Injectables Market Size (2018-2029)
1.6.1 North America Long-Acting Injectables Market Size (2018-2029)
1.6.2 Europe Long-Acting Injectables Market Size (2018-2029)
1.6.3 Asia-Pacific Long-Acting Injectables Market Size (2018-2029)
1.6.4 Latin America Long-Acting Injectables Market Size (2018-2029)
1.6.5 Middle East & Africa Long-Acting Injectables Market Size (2018-2029)
2 Long-Acting Injectables Market by Type
2.1 Introduction
2.1.1 Small and Middle Sized Molecule
2.1.2 Large Sized Molecule
2.2 Global Long-Acting Injectables Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Long-Acting Injectables Historic Market Size by Type (2018-2023)
2.2.2 Global Long-Acting Injectables Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Long-Acting Injectables Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Long-Acting Injectables Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Long-Acting Injectables Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Long-Acting Injectables Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Long-Acting Injectables Revenue Breakdown by Type (2018-2029)
3 Long-Acting Injectables Market Overview by Application
3.1 Introduction
3.1.1 Schizophrenia
3.1.2 Other Psychotic Disorders
3.2 Global Long-Acting Injectables Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Long-Acting Injectables Historic Market Size by Application (2018-2023)
3.2.2 Global Long-Acting Injectables Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Long-Acting Injectables Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Long-Acting Injectables Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Long-Acting Injectables Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Long-Acting Injectables Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Long-Acting Injectables Revenue Breakdown by Application (2018-2029)
4 Long-Acting Injectables Competition Analysis by Players
4.1 Global Long-Acting Injectables Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2022)
4.3 Date of Key Players Enter into Long-Acting Injectables Market
4.4 Global Top Players Long-Acting Injectables Headquarters and Area Served
4.5 Key Players Long-Acting Injectables Product Solution and Service
4.6 Competitive Status
4.6.1 Long-Acting Injectables Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Long-Acting Injectables Products, Services and Solutions
5.1.4 Eli Lilly Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Long-Acting Injectables Products, Services and Solutions
5.2.4 Pfizer Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Long-Acting Injectables Products, Services and Solutions
5.3.4 GlaxoSmithKline Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Long-Acting Injectables Products, Services and Solutions
5.4.4 Johnson & Johnson Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Lupin
5.5.1 Lupin Profile
5.5.2 Lupin Main Business
5.5.3 Lupin Long-Acting Injectables Products, Services and Solutions
5.5.4 Lupin Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.5.5 Lupin Recent Developments
5.6 Zogenix
5.6.1 Zogenix Profile
5.6.2 Zogenix Main Business
5.6.3 Zogenix Long-Acting Injectables Products, Services and Solutions
5.6.4 Zogenix Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.6.5 Zogenix Recent Developments
5.7 DURECT
5.7.1 DURECT Profile
5.7.2 DURECT Main Business
5.7.3 DURECT Long-Acting Injectables Products, Services and Solutions
5.7.4 DURECT Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.7.5 DURECT Recent Developments
5.8 Medincel
5.8.1 Medincel Profile
5.8.2 Medincel Main Business
5.8.3 Medincel Long-Acting Injectables Products, Services and Solutions
5.8.4 Medincel Long-Acting Injectables Revenue (US$ Million) & (2018-2023)
5.8.5 Medincel Recent Developments
6 North America
6.1 North America Long-Acting Injectables Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Long-Acting Injectables Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectables Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Long-Acting Injectables Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectables Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Long-Acting Injectables Market Dynamics
11.1 Long-Acting Injectables Industry Trends
11.2 Long-Acting Injectables Market Drivers
11.3 Long-Acting Injectables Market Challenges
11.4 Long-Acting Injectables Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
